GSK_ Annual_Report_2021-22

149 Notes to the Standalone Financial Statements for the year ended March 31, 2022 Note 46 : Disclosures as required by Micro, Small and Medium Enterprises Development Act, 2006 are as under: ( ` in lakhs) As at March 31, 2022 As at March 31, 2021 (a) The principal amount and the interest due thereon remaining unpaid to suppliers (i) Principal 7,19.19 4,64.80 (ii) Interest due thereon 55.21 62.14 7,74.40 5,26.94 (b) (i) The delayed payments of principal amount paid beyond the appointed date during the entire accounting year 28,95.80 31,87.11 (ii) Interest actually paid under Section 16 of the Micro, Small and Medium Enterprises Development Act, 2006 - - (c) (i) Normal Interest accrued during the year, for all the delayed payments, as per the agreed terms - - (ii) Normal Interest payable for the period of delay in making payment, as per the agreed terms - - (d) (i) Total Interest accrued during the year (ii) Total Interest accrued during the year and remaining unpaid - 0.84 The above information regarding Micro, Small and Medium enterprises has been determined to the extent such parties have been identified on the basis of information available with the Company. - 0.84 Note 47 : Tax expense (a) Amounts recognised in the Statement of Profit and Loss ( ` in lakhs) As at March 31, 2022 As at March 31, 2021 Current tax (for continuing and discontinued operations) Current tax on profits for the year 613,65.21 184,30.17 Current tax on account of earlier years 187,93.59 - Total current tax expense 801,58.80 184,30.17 Deferred tax (for continuing and discontinued operations) In respect of current year (10,49.39) 7,86.69 Adjustment to deferred tax attributable to change in income tax rate - - Total Deferred tax (benefit) / expense (10,49.39) 7,86.69 Total tax expense 791,09.41 192,16.86 Total tax expense attributable to :- from continuing operations 396,86.79 166,53.92 from discontinued operations 394,22.62 25,62.94 Total tax expense 791,09.41 192,16.86 (b) Amounts recognised in Other Comprehensive Income (OCI) Year ended March 31, 2022 Year ended March 31, 2021 Before tax Tax (expense) / benefit Net of tax Before tax Tax (expense) / benefit Net of tax Items that will not be reclassified to the Statement of Profit and Loss Remeasurements of the defined benefit plans (2,46.59) 62.06 (1,84.53) (2,73.74) 68.90 (2,04.84) (2,46.59) 62.06 (1,84.53) (2,73.74) 68.90 (2,04.84)